1. Home
  2. PSTV vs HUBC Comparison

PSTV vs HUBC Comparison

Compare PSTV & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • HUBC
  • Stock Information
  • Founded
  • PSTV 1996
  • HUBC 2017
  • Country
  • PSTV United States
  • HUBC Israel
  • Employees
  • PSTV N/A
  • HUBC N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • HUBC
  • Sector
  • PSTV Health Care
  • HUBC
  • Exchange
  • PSTV Nasdaq
  • HUBC Nasdaq
  • Market Cap
  • PSTV 10.4M
  • HUBC 19.3M
  • IPO Year
  • PSTV N/A
  • HUBC N/A
  • Fundamental
  • Price
  • PSTV $0.34
  • HUBC $2.77
  • Analyst Decision
  • PSTV Strong Buy
  • HUBC
  • Analyst Count
  • PSTV 3
  • HUBC 0
  • Target Price
  • PSTV $10.83
  • HUBC N/A
  • AVG Volume (30 Days)
  • PSTV 65.4M
  • HUBC 2.0M
  • Earning Date
  • PSTV 08-13-2025
  • HUBC 05-01-2025
  • Dividend Yield
  • PSTV N/A
  • HUBC N/A
  • EPS Growth
  • PSTV N/A
  • HUBC N/A
  • EPS
  • PSTV N/A
  • HUBC N/A
  • Revenue
  • PSTV $5,206,000.00
  • HUBC $29,562,000.00
  • Revenue This Year
  • PSTV $14.10
  • HUBC N/A
  • Revenue Next Year
  • PSTV $7.96
  • HUBC N/A
  • P/E Ratio
  • PSTV N/A
  • HUBC N/A
  • Revenue Growth
  • PSTV N/A
  • HUBC N/A
  • 52 Week Low
  • PSTV $0.16
  • HUBC $1.72
  • 52 Week High
  • PSTV $2.31
  • HUBC $14.00
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 49.71
  • HUBC 70.56
  • Support Level
  • PSTV $0.27
  • HUBC $1.98
  • Resistance Level
  • PSTV $0.37
  • HUBC $2.18
  • Average True Range (ATR)
  • PSTV 0.05
  • HUBC 0.22
  • MACD
  • PSTV 0.01
  • HUBC 0.11
  • Stochastic Oscillator
  • PSTV 61.59
  • HUBC 74.64

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

Share on Social Networks: